Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001519:Behavior / Q000187:drug effects*; D002375:Catalepsy / Q000139:chemically induced*; D002746:Chlorpromazine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D010275:Parasympathetic Nervous System / Q000502:physiology*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects*; D013378:Substantia Nigra / Q000502:physiology; D013881:Thioridazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D014149:Tranquilizing Agents; D010830:Physostigmine; D000661:Amphetamine; D012601:Scopolamine; D013881:Thioridazine; D002746:Chlorpromazine